Contracts Finder · Award

Capital - IP-412 - Bio Version Machines

A public procurement published by Nottingham University Hospitals NHS Trust via Contracts Finder.

Contracts FinderAward
£81.2k
Award value
£40.6k
Tender value
1
Suppliers
2
Awards
2
Notices
Award
Stage

Overview

NHSSC RENAL REPLACEMENT THERAPIES SERVICES, TECHNOLOGIES AND CONSUMABLES, OJEU Reference Number 2019/S 205-499640

Key details

Source
Contracts Finder
Lifecycle stage
Award
Status
complete
CPV classification
33181100 — Haemodialysis devices
Currency
GBP
Total award value
£81,180
Tender value
£40,590
First published
14 Oct 2022
Last updated
14 Oct 2022
View the original notice

Awards

2 awards recorded on this procurement.

SupplierCompanies HouseAwardedStatusValue
BAXTER HEALTHCARE LIMITED004613653 Aug 2022active£40.6k
BAXTER HEALTHCARE LIMITED004613653 Aug 2022active£40.6k

Notice timeline

Every published notice in this procurement's lifecycle.

  1. Award noticeCapital - IP-412 - Bio Version Machines
  2. Award noticeCapital - IP-412 - Bio Version Machines

All suppliers

Frameworks & programmes

More from Nottingham University Hospitals NHS Trust

FAQs about this procurement

Who is the buyer for "Capital - IP-412 - Bio Version Machines"?

Capital - IP-412 - Bio Version Machines is a UK public-sector procurement published by Nottingham University Hospitals NHS Trust via Contracts Finder.

Has "Capital - IP-412 - Bio Version Machines" been awarded?

Yes — 2 awards are recorded, with a reported total value of £81,180. The current lifecycle stage is "Award".

Which suppliers are involved in "Capital - IP-412 - Bio Version Machines"?

1 supplier is linked: BAXTER HEALTHCARE LIMITED.

What is "Capital - IP-412 - Bio Version Machines" worth?

The reported award value is £81,180.

When was "Capital - IP-412 - Bio Version Machines" published?

It was first published on 14 Oct 2022 and last updated on 14 Oct 2022, across 2 notices.

Track procurements like this one

Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.

Get in touch with Enable